HomeMLYS • NASDAQ
add
Mineralys Therapeutics Inc
Previous close
$9.36
Day range
$8.90 - $9.39
Year range
$7.95 - $16.91
Market cap
453.89M USD
Avg Volume
211.28K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 60.11M | 128.77% |
Net income | -56.34M | -147.55% |
Net profit margin | — | — |
Earnings per share | -1.13 | -98.25% |
EBITDA | -60.10M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 263.60M | 3.88% |
Total assets | 268.25M | -3.35% |
Total liabilities | 31.32M | 131.27% |
Total equity | 236.93M | — |
Shares outstanding | 49.77M | — |
Price to book | 1.97 | — |
Return on assets | -51.22% | — |
Return on capital | -57.02% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -56.34M | -147.55% |
Cash from operations | -50.19M | -163.71% |
Cash from investing | 79.60M | 1,886.65% |
Cash from financing | -1.00K | -100.54% |
Net change in cash | 29.42M | 298.23% |
Free cash flow | -28.77M | -168.16% |
About
Founded
2019
Website
Employees
28
